Related Experiment Videos
Identification and characterization of cathepsin B as the cellular MARCKS cleaving enzyme
1Howard Hughes Medical Institute, Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA.
Abstract:
The importance of regulating the cellular concentrations of the myristoylated alanine-rich C kinase substrate (MARCKS), a major cellular substrate of protein kinase C, is indicated by the fact that mice lacking MARCKS exhibit gross abnormalities of central nervous system development and die shortly after birth. We previously identified a novel means of regulating cellular MARCKS concentrations that involved a specific proteolytic cleavage of the protein and implicated a cysteine protease in this process (Spizz, G., and Blackshear, P. J. (1996) J. Biol. Chem. 271, 553-562). Here we show that p40, the carboxyl-terminal fragment resulting from this cleavage of MARCKS, was associated with the mitochondrial/lysosomal pellet fraction of human diploid fibroblasts and that its generation in cells was sensitive to treatment with NH4Cl. These data suggest the involvement of lysosomes in the generation and/or stability of p40. The MARCKS-cleaving enzyme (MCE) activity was peripherally associated with a 10,000 x g pellet fraction from bovine liver, and it co-purified with the activity and immunoreactivity of a lysosomal protease, cathepsin B. Cathepsin B catalyzed the generation of p40 from MARCKS in a cell-free system and behaved similarly to the MCE with respect to mutants of MARCKS previously shown to be poor substrates for the MCE. Treatment of fibroblasts with a cell-permeable, specific inhibitor of cathepsin B, CA074-Me, resulted in parallel time- and concentration-dependent inhibition of cathepsin B and MCE activity. Incubation of a synthetic MARCKS phosphorylation site domain peptide with purified cathepsin B resulted in cleavage of the peptide at sites consistent with preferred cathepsin B substrate sites. These data provide evidence for the identity of the MCE as cathepsin B and suggest that this cleavage most likely takes place within lysosomes, perhaps as a result of specific lysosomal targeting sequences within the MARCKS primary sequence. The data also suggest a direct interaction between MARCKS and cathepsin B in cells and leave open the possibility that MARCKS may in some way regulate the protease for which it is a substrate.
Insights
The myristoylated alanine-rich C kinase substrate (MARCKS) is cleaved by cathepsin B, likely within lysosomes. This process regulates cellular MARCKS levels and may involve MARCKS influencing cathepsin B activity.
Area of Science:
- Cell Biology
- Biochemistry
- Molecular Biology
Background:
- Myristoylated alanine-rich C kinase substrate (MARCKS) is crucial for CNS development; its absence is lethal.
- MARCKS regulation involves proteolytic cleavage, with a cysteine protease implicated.
- The carboxyl-terminal fragment (p40) is linked to lysosomes, suggesting their involvement in MARCKS processing.
Purpose of the Study:
- To identify the enzyme responsible for MARCKS cleavage.
- To elucidate the cellular location and mechanism of MARCKS p40 fragment generation.
- To investigate the role of cathepsin B in MARCKS regulation.
Main Methods:
- Fractionation of human diploid fibroblasts and bovine liver.
- Enzyme assays using purified cathepsin B and MARCKS fragments.
- Inhibition studies with cathepsin B-specific inhibitor CA074-Me.
- Analysis of MARCKS mutants and synthetic peptides.
Main Results:
- p40 fragment generation was lysosome-associated and NH4Cl-sensitive.
- MARCKS-cleaving enzyme (MCE) activity co-purified with cathepsin B.
- Purified cathepsin B generated p40 from MARCKS in vitro.
- Cathepsin B inhibition paralleled MCE inhibition; peptide cleavage sites matched cathepsin B preference.
Conclusions:
- Cathepsin B is the MARCKS-cleaving enzyme (MCE).
- MARCKS cleavage likely occurs within lysosomes.
- MARCKS may possess lysosomal targeting sequences and potentially regulate cathepsin B.